Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-01-08 @ 11:10 AM
Study NCT ID:
NCT00581360
Status:
COMPLETED
Last Update Posted:
2016-11-07
First Post:
2007-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Sponsor:
University of Pittsburgh
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-19
First Submit QC Date:
None
Study First Post Date:
2007-12-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-14
Results First Submit QC Date:
None
Results First Post Date:
2016-11-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-19
Last Update Post Date:
2016-11-07
Last Update Post Date Type:
ESTIMATED